Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00334282 · OUTCOME

Duration of Response

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma · Source last updated 2016-02-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
weeks
Interval / dispersion
95% Confidence Interval
Time frame
Time from response until progression (up to 2 years)

What was measured

Duration of response is defined as the time from first observation of response until progression of disease or death.

Analysis population: ITT Population. Only results for pazopanib are given because there were not enough placebo responders.

Groups in this outcome

Pazopanib 800 mg

Pazopanib 800 mg (tablets) administered orally once a day

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pazopanib 800 mg290

Reported measurements

Source class 1
Values in weeks · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Pazopanib 800 mg58.7Not reported52.168.1Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        52.1
        upper Limit
        68.1
        value
        58.7
denoms
  1. counts
    1. group Id
      OG000
      value
      290
    units
    Participants
description
Duration of response is defined as the time from first observation of response until progression of disease or death.
dispersion Type
95% Confidence Interval
groups
  1. description
    Pazopanib 800 mg (tablets) administered orally once a day
    id
    OG000
    title
    Pazopanib 800 mg
param Type
MEDIAN
population Description
ITT Population. Only results for pazopanib are given because there were not enough placebo responders.
reporting Status
POSTED
time Frame
Time from response until progression (up to 2 years)
title
Duration of Response
type
SECONDARY
unit Of Measure
weeks

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice